I Junghahn

550 total citations
23 papers, 450 citations indexed

About

I Junghahn is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, I Junghahn has authored 23 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Hematology. Recurrent topics in I Junghahn's work include Hematopoietic Stem Cell Transplantation (5 papers), Mesenchymal stem cell research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). I Junghahn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Mesenchymal stem cell research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). I Junghahn collaborates with scholars based in Germany and United Kingdom. I Junghahn's co-authors include Iduna Fichtner, Jutta Aumann, Michael W. Becker, Andreas Nitsche, Catherine M. Neumann, Reinhard Henschler, P. Langen, Peter Kufer, Antônio da Silva and Bernd Schlereth and has published in prestigious journals such as Blood, Cancer Research and British Journal of Cancer.

In The Last Decade

I Junghahn

21 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Junghahn Germany 11 211 128 116 89 82 23 450
Piao Lo United States 6 269 1.3× 163 1.3× 149 1.3× 84 0.9× 53 0.6× 7 537
Marilyn A. Niemann United States 14 177 0.8× 47 0.4× 189 1.6× 64 0.7× 136 1.7× 20 475
Janet Stiernberg United States 8 226 1.1× 42 0.3× 95 0.8× 62 0.7× 166 2.0× 9 507
Oliver Hiller Germany 10 134 0.6× 126 1.0× 91 0.8× 48 0.5× 114 1.4× 14 459
Reed Jc United States 8 312 1.5× 149 1.2× 103 0.9× 139 1.6× 21 0.3× 12 483
Derrick L. Domingo United States 7 211 1.0× 55 0.4× 201 1.7× 49 0.6× 66 0.8× 7 445
I R Kirsch United States 9 463 2.2× 103 0.8× 209 1.8× 77 0.9× 45 0.5× 14 687
Elizabeth B. Mushinski United States 10 368 1.7× 178 1.4× 225 1.9× 32 0.4× 70 0.9× 13 628
Jane Wass Australia 12 183 0.9× 95 0.7× 49 0.4× 32 0.4× 38 0.5× 22 419
Michael Nawrath Switzerland 15 291 1.4× 125 1.0× 199 1.7× 38 0.4× 33 0.4× 23 544

Countries citing papers authored by I Junghahn

Since Specialization
Citations

This map shows the geographic impact of I Junghahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Junghahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Junghahn more than expected).

Fields of papers citing papers by I Junghahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Junghahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Junghahn. The network helps show where I Junghahn may publish in the future.

Co-authorship network of co-authors of I Junghahn

This figure shows the co-authorship network connecting the top 25 collaborators of I Junghahn. A scholar is included among the top collaborators of I Junghahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Junghahn. I Junghahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henschler, Reinhard, I Junghahn, Gesine Bug, et al.. (2005). Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers. Leukemia Research. 29(10). 1191–1199. 11 indexed citations
2.
Schlereth, Bernd, Iduna Fichtner, Grit Lorenczewski, et al.. (2005). Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct. Cancer Research. 65(7). 2882–2889. 101 indexed citations
3.
Nitsche, Andreas, I Junghahn, Stefanie Thulke, et al.. (2003). Interleukin‐3 Promotes Proliferation and Differentiation of Human Hematopoietic Stem Cells but Reduces Their Repopulation Potential in NOD/SCID Mice. Stem Cells. 21(2). 236–244. 38 indexed citations
4.
Becker, Michael W., Andreas Nitsche, Catherine M. Neumann, et al.. (2002). Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. British Journal of Cancer. 87(11). 1328–1335. 99 indexed citations
5.
6.
Nitsche, Andreas, Michael W. Becker, I Junghahn, et al.. (2001). Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction.. PubMed. 86(7). 693–9. 20 indexed citations
7.
Junghahn, I, Manuela Wissler, Michael W. Becker, et al.. (2000). Donor stromal cells from human blood engraft in NOD/SCID mice. Blood. 96(12). 3971–3978. 27 indexed citations
8.
Junghahn, I, Julia Winkler, Iduna Fichtner, et al.. (1999). Differential Kinetics of Primitive Hematopoietic Cells Assayed In Vitro and In Vivo During Serum‐Free Suspension Culture of CD34 + Blood Progenitor Cells. Stem Cells. 17(3). 152–161. 38 indexed citations
10.
Schwarz, K., Stephanie von Harsdorf, C. von Schilling, et al.. (1996). Fibroblasts retrovirally transfected with the human IL-3 gene initiate and sustain multilineage human hematopoiesis in SCID mice: comparison of CD34-enriched vs CD34-enriched and in vitro expanded grafts.. PubMed. 18(3). 513–9. 11 indexed citations
11.
Junghahn, I, et al.. (1995). Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene.. PubMed. 15(2). 449–54. 7 indexed citations
12.
Bergmann, J., I Junghahn, H. Brachwitz, & P. Langen. (1994). Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line.. PubMed. 14(4A). 1549–56. 27 indexed citations
13.
Junghahn, I, et al.. (1992). The role of elongation factors in protein synthesis rate variation in white teleost muscle. Journal of Comparative Physiology B. 162(4). 345–50. 5 indexed citations
14.
Bielka, H, Rainer Benndorf, & I Junghahn. (1988). Growth related changes in protein synthesis and in a 25 kDa protein of Ehrlich ascites tumor cells.. PubMed. 47(7). 557–63. 4 indexed citations
15.
Junghahn, I & Karl Jürss. (1988). Effects of feeding and salinity on protein synthesis in the white epaxial muscle of the rainbow trout (Salmo gairdneri Richardson). Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 89(2). 329–333. 7 indexed citations
16.
Junghahn, I & Ulrich‐Axel Bommer. (1987). Age dependent changes in the activity of the cytosolic fraction from rat liver to stimulate polysomal protein synthesis and the role of initiation factor eIF-2.. PubMed. 46(11). 791–4. 2 indexed citations
17.
Bielka, H, Richard Grosse, F.D. Böhmer, I Junghahn, & Bert Binas. (1986). Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis.. PubMed. 45(4). 441–5.
18.
Franz, Hartmut, et al.. (1983). Differences in toxicity and antigenicity between mistletoe lectin I and viscotoxin A 3.. PubMed. 42(5). K21–5. 5 indexed citations
19.
Junghahn, I, et al.. (1975). Cycloheximide resistance in Chinese hamster cells. III. Characterization of cell-free protein synthesis by polysomes.. PubMed. 138(2). 173–7. 17 indexed citations
20.
Bielka, H, et al.. (1964). Untersuchungen zur Struktur ribosomaler RNS aus Normal- und Tumorgeweben. Zeitschrift für Naturforschung B. 19(12). 1121–1126. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026